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SPECIAL ARTICLE
The status of CMV as a human pathogen
Cytomegalovirus (CMV) is a common infectious agent which is well adapted to
its host. Following primary infection, which is almost always asymptomatic in
people with normal immunity, the virus establishes latency at sites which are
unknown. The virus is probably maintained in this latent state by immune
surveillance mechanisms since immunosuppression frequently leads to reac-
tivation of virus.
Cytomegalovirus has been identified in most anatomical areas of the human
body. The aim of this article is to define criteria for pathogenicity so that clinical
and experimental data can be reviewed to determine if CMV is likely to cause
disease at these various clinical sites. Thus, patients have been shown to die
frequently with CMV but do they die from it ?
POTENTIAL MECHANISMS OF PATHOGENICITY
There are several mechanisms whereby CMV could induce disease in its human
host.
Direct viral lysis
Cytomegalovirus may cause tissue damage by infecting, replicating and
ultimately lysing target cells. We believe that Class IHLA molecules represent the
major cellular receptor for CMV (Grundy, Shanley & Griffiths, 1987) which exists
in body fluids coated with the host protein /?2-microglobulin (McKeating, Griffiths
& Grundy, 1987). Potentially, therefore, all nucleated cells within the body could
be targets for CMV replication and lysis.
Immunopathology
Cytomegalovirus could initiate infection of target cells as above but without
necessarily proceeding through a full replicative cycle. The expression of virus-
specified immediate-early (IE) or early (E) antigens, either as whole proteins or
peptide fragments on the cell surface, would be sufficient to make the cell
vulnerable to attack by cytotoxic T-lymphocytes (Borysiewicz et al. 1983). In
this case, the damage would be triggered by the virus but would be caused by the
body's cell-mediated immune response. Cells supporting the full replicative cycle
of CMV would also be targets for such responses since IE and E antigens appear
in these cells prior to virus replication and since CMV structural proteins (or
fragments thereof) could also be recognized by cytotoxic T-cells. Triggering of
delayed-typc hyperscnsitivity T cells could similarly lead to destructive
inflammatory responses.
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Triggering of' autoimmunity'
By perturbing the cell membrane of a non-productively infected cell, CMV could
induce cytotoxic T-lymphocyte responses against host antigens. Alternatively,
CMV infection of or interaction with lymphocytes could induce a polyclonal
activation of T or B cells, resulting in the expansion of clones with reactivity
against self-antigens. Furthermore, interferon release, stimulated by CMV
infection, would increase HLA display on uninfected cells leading to accentuation
of graft rejection or graft versus host disease (GVHD).
Synergy
Synergism between CMV and another virus could induce disease not produced
by either virus alone. For example, asymptomatic CMV infection of the brain
could recruit to that organ macrophages bearing latent human immunodeficiency
virus (HIV) which could then reactivate to cause encephalitis. Likewise,
asymptomatic CMV or HIV infection of bystander lymphocytes or macrophages
could induce release of lymphokines which could support the growth of
neighbouring cells infected with the other virus. Alternatively, synergy between
CMV and HIV could readily occur if one virus impaired the immune surveillance
required for the suppression of replication of the other. Finally, expression of
regulatory regions of the CMV genome (Stinski & Roehr, 1985) could lead to trans-
activation of latent HIV genomes resulting in viral lysis of the HIV infected
cells.
Oncogenidty
Cytomegalovirus has a very large DNA genome with complex control
mechanisms which lead to the ordered appearance of its specified proteins during
replicative cycles (reviewed by Griffiths & Grundy, 1987). If integration of the
CMV genome occurred into host DNA, these control sequences could influence
expression of host oncogenes by the mechanisms of promoter insertion, enhancer
insertion or genome translocation as has been described for other viruses (Weiss,
1985). Alternatively, partial expression of the CMV genome could lead to
transactivation of host oncogenes. Two distinct subgenomic fragments have been
reported to have transforming activity (Nelson et al. 1982; Clanton et al. 1983).
If CMV contains an oncogene homologue, as has been claimed (Spector &
Vacquier, 1983), this potentially could directly induce altered growth charac-
teristics in infected cells.
CRITERIA TO BE SATISFIED
In this section we define certain general criteria whose fulfilment for any given
syndrome would support the concept that CMV is acting as a pathogen. Not all
criteria would have to be met before pathogenicity was accepted but the strongest
cases would be expected to meet most.
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Table 1. Association between CMV infection at particular anatomical sites and
dysfunction of those organs
Patient group*
A
I \
Site of Organ Renal Marrow Congenital Infant
infection dysfunction? transplant transplant AIDS infection infection
Salivary gland No + + + + +
Kidney No + + + + +
Retina Yes + + H- + •
Liver Yes + + + + •
Lung Yes + + + + +
Brain Yes + +
Colon Yes + + +
* + indicates infection at these sites.
1. CMV should be found at the clinically involved site in the absence of other
pathogens
Table 1 shows the sites of the body from which CMV has been isolated regularly.
The data, as presented, suggest that CMV infection of the salivary gland and
kidney does not produce disease but that this virus is pathogenic at all other sites.
However, a selection bias may be present. Since only diseased organs are biopsied,
any agent, such as CMV, which is found in most organs will be associated with that
disease but may not be the aetiological agent.
2. Disease should occur in those with high CMV titres
If CMV is damaging by way of lytic infection then disease should be directly
correlated with high CMV titres. There are problems of course in attempting to
measure virus titres in biopsies from affected organs such as inner ear or brain. We
have therefore accepted data on virus titres in urine as fulfilling this criterion.
3. Effective antiviral chemotherapy should suppress disease
Therapy with ganciclovir is fairly effective at reducing the titre of CMV in
humans (Collaborative Study, 1986). If disease was caused by lytic infection, then
one would expect therapy to hasten resolution of disease.
Notice that failure to satisfy this criterion does not indicate that CMV is not
pathogenic. As discussed earlier, CMV may be causing disease by expression of
only IE or E antigens on infected cells which can then act as targets for
immunopathological processes. Since drugs like ganciclovir operate only at the
DNA replication stage (Tocci el al. 1984), which occurs after IE and E gene
expression, these drugs would not be expected to inhibit immunopathological
conditions.
4. Animal models should reproduce the CMV syndromes
This criterion is difficult to satisfy for human CMV since the virus is highly
species-specific and so animal experiments with the human virus cannot be
performed. However, all species so far tested have their own species-specific
cytomegaloviruses and murine CMV infection of mice, rat CMV infection of rats
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Table 2. Induction by murine CMV of organ dysfunction in various
groups of mice
Effect of MCMV seen in
Normal Newborn Immunocompromized Effect of
Syndrome mice mice only mice only immunity
Hepatitis + • • Protective
Eye infection + • • Protective
Microcephaly •
Ear infection • + • Protective
Mononucleosis +
Immiuriosuppression +
Pneumonitis . • + Damaging
Gastrointestinal infection +
Allograft effects + • • Damaging
Encephalitis • + + Protective
and guinea-pig CMV infection of guinea-pigs have all been used as animal models
of the human infection. The mouse model has been studied intensively (reviewed
by Osborn, 1982; Hamilton, 1982) and murine CMV (MCMV) has been shown to
infect all of the organs associated with the human disease (see Table 2). However,
since murine CMV does not cross the placenta in mice (Johnson, 1964), congenital
infection cannot be studied in this model (this is thought to be due to differences
in the structure of the placenta in the mouse and man rather than differences
between the two viruses).
Note that not all of the mouse models mirror the human conditions exactly. For
example, MCMV causes labyrinthitis in the mouse which is different histologically
from the endolymphatic labyrinthitis seen in humans (Davis & Strauss, 1973) and
also infects the vascular tissues of the eye rather than the retina and choroid as
seen in humans (Hudson, 1979). These discrepancies may be due to differences in
the route of infection in the experimental and natural situations and so we have
accepted virus infection of the same organ as fulfilment of this criterion.
5. Immunity against the virus should prevent disease
If the virus infection is the cause of the syndrome then prevention of infection
should be associated with control of disease Unfortunately, however, the live
passaged vaccine strains used to date have not provided convincing evidence of
protection against CMV infection (Plotkin el al. 1984). We have therefore
evaluated this criterion by reference to the ability of naturally induced immunity
to moderate the pathology found in each syndrome.
SYNDROMES REPORTED TO BE ASSOCIATED WITH CMV
CM V mononucleosis
Although most cases of primary CMV infection in apparently healthy
individuals remain asymptomatic, occasional cases of a mononucleosis-like illness
are seen. CMV mononucleosis is a febrile illness accompanied by a lymphocytosis
and atypical lymphocytes are found in the peripheral blood (Klemola &
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Kaariainen, 1965; Kantor et al. 1970; Jordan et al. 1973). However, when
compared to infectious mononucleosis caused by Epstein-Barr virus, exudative
pharyngitis is not a feature of CMV mononucleosis, the Paul Bunnell test is
negative and lymphadenopathy is less commonly seen (Klemola & Kaariainen,
1965; Kantor et al. 1970; Jordan et al. 1973). Hepatomegaly and splenomegaly are
often seen in patients with CMV mononucleosis (Kantor et al. 1970; Jordan et al.
1973) and hepatitis can be a presenting symptom (see below). Haemolytic
anaemia, thrombocytopenia and myocarditis can also be features of CMV
mononucleosis (discussed below). In addition, various immunologic abnormalities
have been observed which disappeared when the mononucleosis-like syndrome
resolved; these include the presence of autoantibodies, cold agglutinins,
rheumatoid factors and cryoglobulins (Kantor et al. 1970). It is estimated that
10-14% of cases of mononucleosis are due to CMV (Hamilton, 1982). When
infectious mononucleosis is transmitted by blood transfusion following open-heart
surgery it is termed the 'post-perfusion syndrome'.
Mononucleosis can be reproduced in the mouse model (Grundy, 1979), as can the
production of autoantibodies (Bartholomaeus et al. 1983) and, being a mani-
festation of primary CMV infection, can be moderated by immunity. Criteria 4
and 5 are therefore satisfied (see Table 3).
Hepatitis
Patients with CMV mononucleosis often have some degree of hepatitis, as
indicated by raised serum levels of liver enzymes. In particular, transaminases are
elevated with variable changes in alkaline phosphatase (Klemola & Kaariainen,
1965; Hanshaw et al. 1965; Jordan et al. 1973). In addition, hepatitis can be the
major presenting symptom of CMV infection in previously healthy adults (Lamb
& Stern, 1966; Carter, 1968; Shusterman, Frauenhoffer & Kinsey, 1978) and this
may be accompanied by jaundice (Lamb & Stern, 1966; Shusterman, Frauenhoffer
& Kinsey, 1978). Cytomegalovirus hepatitis has also been described following
blood transfusion (Toghill et al. 1967; Fiala et al. 1974). Cytomegalovirus has not
been found to be associated with chronic liver disease (Toghill, Williams & Stern,
1969).
Immunosuppressed adults (reviewed by Glenn, 1981; Meyers, Flournoy &
Thomas, 1986) may develop hepatitis alone. More frequently, hepatitis is part of
disseminated infection with viraemic spread to multiple organs. Thus, although
the hepatitis itself is not life-threatening, it represents a poor prognostic sign for
the patient.
Hepatitis is frequently found in cases of congenital CMV infection. The
hyperbilirubinacmia is in both the direct and indirect fractions and is rarel\T
sufficient to cause kernicterus (Hanshaw, Dudgeon & Marshall, 1985). The
condition usually resolves during the first year of life.
Cytomegalovirus has been cultured from liver biopsies and the hepatitis appears
to respond to ganciclovir (Collaborative Study, 1986). The syndrome can be
reproduced in the mouse model (Mohamed, 1974; Grundy, 1979; Papadimitriou,
Shellam & Allan, 1982) and pre-existing immunity against CMV protects against
hepatitis. Criteria 1, 3, 4 and 5 are therefore considered proven.
6 P. D. GRIFFITHS AND J. E. GRUNDY
Table 3. Criteria for pathogenicity which have been satisfied in
specified clinical syndromes
Criteria +
Syndrome
Mononucleosis
1 2 :
Hepatitis +
Haemolytic anaemia
Thrombocytopenia
Retinitis +
Gastrointestinal infection +
-
-
Microcephaly + +
Hearing loss + . +
Immunosuppression
Pneumonitis-allografts +
Pneumonitis-AIDS
Allograft effects
Encephalitis
Kaposi's sarcoma
Prostatic carcinoma
Colonic carcinoma
* * Is CMV
J 4 5 pathogenic?
+ + Yes
h + + Yes
+ + Yes
+ + Yes
(- + Yes
h + • Yes
+ * Yes
+ * Yes
+ + Yes
+ • Yes
+ - Possibly
+ • Possibly
+ • Possibly
Unlikely
No
No
Mechanism of
pathogenicity
Lytic
•
•
Lytic
Lytic ?
•
•
•
Immunopathology ?
Lytic ?
Viral synergy ?
•
•
+ See text for details. * Maternal immunity.
Haemolytic anaemia
Haemolytic anaemia is occasionally seen in infants with congenital CMV
infection (Hanshaw, Dudgeon & Marshall, 1985) but has also been reported during
CMV infection in previously healthy individuals (Hams, Meyer & Brody, 1975;
Coombs, 1968) and more frequently in adults who had received blood transfusions
(Kantor el al. 1970; Kantor & Goldberg, 1971; Holt & Kirkham, 1976). Both
Coombs'-positive and Coombs'-negative anaemias have been reported (Zuelzer
et al. 1970).
Thrombocytopenia
Thrombocytopenia is a common feature of congenital CMV infection (Hanshaw,
Dudgeon & Marshall, 1985). In CMV infection of adults, thrombocytopenia has
been described either accompanying (Harris, Meyer & Brody, 1975) or in the
absence (Chanarin & Walford, 1973; Fiala, Kattlove & Lemkin, 1973) of
haemolysis.
Haemolytic anaemia (Grundy, 1979) and thrombocytopenia (Osborn & Shahidi,
1973) can be reproduced in animal models and are often manifestations of primary
infections; criteria 4 and 5 are therefore satisfied for both.
Retinitis
Cytomegalovirus retinitis is seen in cases of congenital CMV who arc born with
symptoms but not in those who are asymptomatic at birth (Pass et al. 1980).
Retinitis is found frequently in AIDS patients (Egbert et al. 1980) and is
occasionally seen in other immunosuppressed individuals. The lesions are
frequently sight-threatening.
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Cytomegalovirus DNA has been detected in the retina (Kennedy et al. 1986),
ganciclovir can effectively suppress the disease process (Collaborative Study,
198G) and animal models are available (Hudson, 1979). Criteria 1, 3 and 4 are
therefore satisfied.
Gastrointestinal infection
Cytomegalovirus has been detected in most parts of the gastrointestinal tract
from the oesophagus to the anus (Wong & Warner, 1962; McDonald et al. 1985).
It is frequently found in the base of ulcers and may be associated with severe
haemorrhage. Such ulcers have been described in patients with normal immunity,
immunosuppressed patients and those with ulcerative colitis.
The clinical response to ganciclovir therapy and the absence of other recognized
pathogens (criteria 3 and 1) indicate that CMV is probably acting as a pathogen
in the gastrointestinal tract.
Microcephaly
Cases of cytomegalic inclusion disease may have microcephaly at birth (Pass
et al. 1980). Others may develop microcephaly during infancy but may also have
impaired intellectual development in the absence of formal microcephaly.
Disease correlates with high viral titres (Stagno et al. 1975). No clear dissociation
has been shown between damage to the ear or brain and it must remain likely that
both organs can be affected by virus lysis although immunopathological processes
can also be implicated (Griffiths et al. 1982). Maternal immunity is partially
protective (Stagno et al. 1982) so we consider criterion 5 to be satisfied (see Table
3).
Hearing loss
Sensorineural hearing loss can occur in congenitally infected babies who are
born with or without symptoms. It may be unilateral or bilateral and may be
profound (Hanshaw, Dudgeon & Marshall, 1985; Pass et al. 1980). Children with
high CMV titres in the urine are at increased risk of hearing loss (Stagno et al. 1975)
but immunopathological processes may also be involved (Griffiths et al. 1982).
Cytomegalovirus has been isolated from the inner ear of a fatal case of
congenital infection (Davis et al. 1979) and from the middle-ear effusion of a 12-
month-old child with conductive hearing loss (Embil, Goldbloom & McFarlane,
1985). Since MCMV can infect the ear (Davis & Strauss, 1973), CMV can be found
at the affected site and maternal immunity is protective (Stagno et al. 1982),
criteria 1, 2 and 5 are considered to be satisfied.
Ifnmunosuppression
Immunosuppression has been described in patients with CMV mononucleosis as
evidenced by decreased responses of peripheral blood lymphocytes to mitogenic
stimulation (Rinaldo et al. 1980). Accessory macrophages were reported to be
responsible for this defect (Carney & Hirsch, 1981) and recently Rodgers et al.
(1985) described an inhibitor of interleukin 1 released by monocytes after exposure
to CMV. However, the latter effect could not be reproduced using stocks of CMV
free from contamination with mycoplasma (Scott & Sissons, 1987) and so it must
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bo concluded that the inhibitory action on interleukin 1 was caused by
mycoplasma.
An immunosuppressive syndrome associated with CMV infection has been seen
in renal transplant patients. It follows an AIDS-like course with opportunistic
superinfections but often resolves spontaneously in those individuals who survive
the acute episode. It is possible that a similar effect may occur with CMV infection
of bone marrow transplant or AIDS patients but the underlying severe
immunosuppression makes this difficult to identify with certainty.
Since this syndrome can be reproduced in mice (reviewed in Griffiths & Grundy,
1987) and is a manifestation of primary infection, criteria 4 and 5 are considered
to be satisfied.
Pneumonilis
Interstitial pneumonitis is a frequent complication of CMV infection in renal
and bone-marrow transplant recipients (Rubin et al. 1981; Meyers, Flournoy &
Thomas, 1986). Histologically, it resembles interstitial pneumonitis seen in
patients with collagen vascular disease (Hammer el al. 1983) and is characterized
by a mononuclear cell infiltrate in the lung septae with perivascular cuffing and
endothelial cell swelling (Beschorner et al. 1980; Hammer et al. 1983). Radiologic
changes may or may not be present (Milburn, Prentice & du Bois, 1987).
Cytomegalovirus pneumonitis in transplant recipients has a case-fatality rate of
approximately 85 % and has been reported to be the single most common cause
of death in bone marrow transplant patients (Watson, 1983; Meyers, Flournoy &
Thomas, 1986).
Most cases of perinatal CMV infection are asymptomatic but occasionally infant
pneumonitis may occur (Stagno et al. 1981). This resembles pneumonitis caused by
Pneumocystis carinii and the patient may require ventilatory support.
AIDS patients frequently have CMV detected in the lung by culture of BAL
fluid but P. carinii is often found in the same specimen (Murray et al. 1984; Stover
et al. 1985). Such patients frequently respond promptly to treatment with co-
trimoxazole irrespective of whether or not CMV was co-infecting the lung.
The mouse model shows that a host immune response is required for CMV-
induced pneumonitis (Shanley, Pesante & Nugent, 1982; Grundy, Shanley &
Shearer, 1985) and that the syndrome can be prevented by continued
immunosuppression. All of the clinical findings in human allograft patients are
consistent with these data so we have hypothesized elsewhere that CMV
pneumonitis in allograft patients is an immunopathological condition while in
AIDS patients lung infection may be asymptomatic or may cause disease through
extensive cell lysis (Grundy, Shanley & Griffiths, 1987). Thus, CMV pneumonitis
in allograft patients fulfils criteria 1 and 4 while the same syndrome in AIDS
patients fulfils only criterion 4 because such patients also have P. carinii in their
lungs.
Allograft effects
Cytomegalovirus infection is often closely associated with rejection episodes in
renal transplant patients (Lopez et al. 1974; May et al. 1978; Pass et al. 1979). It
is a moot point whether the virus triggers the adverse response or whether the
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immunosuppressive effect of the treatment required for the suppression of renal
rejection episodes induces reactivation of CMV. However, in the mouse model
MCMV infection has been shown to enhance the cytotoxic T-cell response to
alloantigens (Grundy & Shearer, 1984; Grundy & Reid, 1985).
Likewise, patients with GVHD following bone-marrow transplantation have
more severe CMV infection, especially pneumonitis (Appelbaum el al. 1982;
Meyers, Flournoy & Thomas, 1986; Miller et al. 1986). However, it is not clear
whether CMV triggers GVHD or whether the profoundly immunosuppressive
effect of GVHD (and that of its treatment) are responsible for CMV reactivation.
In the mouse model, CMV has been shown to accentuate the GVH reaction
(Grundy, Shanley & Shearer, 1985).
Since only the mouse data provide evidence of CMV actually causing these
allograft effects, we cannot conclude that CMV is pathogenic in humans, although
this remains a strong possibility (see Table 3).
Encephalitis
Encephalitis due to CMV has been described in AIDS patients but not in other
immunosuppressed individuals. The patients present with memory loss and
impaired intellectual function. Human immunodeficiency virus is frequently also
found in brain macrophages from AIDS patients with encephalitis (reviewed by
Carne, 1987). Cytomegalovirus may be pathogenic in this setting but we consider
it to be unproven at this time, with support only for criterion 4 following
intracerebral inoculation of MCMV (Lussier, 1973, 1975; Hudson, 1979).
KaposVs sarcoma
Fifteen years ago, cultures of cells derived from Kaposi's sarcoma (KS) tissue
were found to contain a herpesvirus which resembled CMV (Giraldo, Beth &
Haguenau, 1972; Giraldo et al. 1972). Serological studies later revealed that
100% of patients with KS have IgG antibodies against CMV. The geometric mean
titre of these antibodies was significantly raised above that of controls in
European cases of KS but not in African cases of KS (Giraldo et al. 1975).
Subsequent publications reported that CMV could not be cultured from KS tissue
but that virus DNA, RNA or proteins could be detected (Giraldo, Beth & Huang,
1980; Boldogh et al. 1981; Drew & Mintz, 1984).
Unfortunately, the studies reported to date have all used nucleic acid probes
prepared from whole virion DNA. Since regions of CMV DNA are now known to
bind avidly to human DNA (Peden, Mounts & Hayward, 1982; Ruger, Bornkamm
& Fleckenstein, 1984), the results claiming to detect CMV DNA or RNA must be
assumed to be unreliable until the experiments have been repeated using cloned
sequences of the virus genome which lack cross-reactivity with host DNA.
Likewise, the studies of virus-specified proteins within KS tissue must be repeated
using monoclonal antibodies of defined specificity before the results can be
accepted. Thus, at the time of writing, the CMV/KS association is based upon
some early seroepidemiology together with the coincidence of KS developing in
AIDS patients who also have CMV infection (Marmor et al. 1984). Clearly, those
who believe that KS may be caused by CMV (Giraldo & Beth, 1986) require more
convincing evidence.
10 P. D. GRIFFITHS AND J. E. GRUNDY
Prostatic carcinoma
Albrecht & Rapp (1973) showed that CMV irradiated with ultraviolet light
could transform hamster fibroblasts and that these cells could produce tumours in
mice. Rapp et al. (1975) reported that cell cultures derived from normal prostate
developed cytopathic changes and that CMV antigens and DNA were detectable
in these cells. Similarly, Geder et al. (1976) showed that unirradiated CMV
prepared from the prostatic tissue described above could transform human
embryo lung fibroblasts and that these could also produce tumours in nude mice
(Geder, Kreider & Rapp, 1977). Passage of the tumour cells in vitro led to
identification of a herpesvirus which was rather confusingly given the initials
HMCV (Hershey Medical Center Virus); this virus has been identified as infectious
bovine rhinotracheitis virus (Geder et al. 1978).
It seems safest to assume that the whole CMV/prostatic carcinoma story is an
unfortunate example of an adventitious virus presumably acquired from fetal calf
serum despite strenuous attempts (Geder et al. 1978) to maintain sterile conditions.
Curiously, however, this interpretation is not discussed in a recent review (Rapp
& Robbins, 1984) where the reference identifying HMCV as infectious bovine
rhinotracheitis is not quoted.
Colonic carcinoma
Cytomegalovirus has been isolated from surgical specimens of colonic adeno-
carcinomas (Hashiro, Horikami & Loh, 1979) and CMV DNA has been reported
to be detectable using whole virus genomic material (Huang & Roche, 1978). In
contrast, Hart, Neill & Norval (1982) could find no association between CMV and
carcinoma of the colon using in situ hybridization and explant techniques.
CONCLUSIONS
It will be seen from Table 3 that some CMV syndromes satisfy several of the
proposed criteria and so we suggest that CMV is causally associated with these
conditions.
Others meet none or only one criterion and so we are reluctant to conclude at
this point that CMV is pathogenic in these settings. In particular, the suggestion
that CMV may be naturally oncogenic is far from proven. The association between
CMV and KS certainly falls far short of that between Epstein-Barr virus and
Burkitt's lymphoma or nasopharyngeal carcinoma. The best that can be said
about the data suggesting that CMV DNA can transform cells or may contain an
oncogene homologue is that it argues against immunization with CMV vaccines
which contain DNA.
Despite the difficulties of working with different viruses, the animal models have
provided good evidence to support the many pathogenic roles of CMV and perhaps
deserve to be read more widely by human virologists. Indeed, the murine models
may give examples of organ-specific damage which have not yet been recognized
in man. For example, Shanley (1987) has shown that athymic nude mice can
develop necrotizing adrenalitis. The possibility that human AIDS patients may
have a similar disease inducing Addisonian crises is an intriguing one which
deserves further study.
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In preparing this review it is clear to us that some of the conclusions in Table
3, although probably supported by most virologists, are still somewhat subjective
and need to be placed upon firmer scientific ground. Perhaps this will only happen
when controlled trials of subunit CMV vaccines show which ' CMV syndromes' can
be prevented.
P. D. GRIFFITHS AND J. E. GRUNDY
Department of Virology
Royal Free Hospital School of Medicine
London NW3, England
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